Seminar Detail

Psychopharmacology for Mental Health Professionals
Psychopharmacology for Mental Health Professionals

Where:   TIMONIUM, MD

When:  Monday, June 24, 2019 at 8:00 AM - 4:00 PM

Credit Card Required for online registration | Contact us to redeem Gift Certificates
Other ways to Register: Call (800) 844-8260   |   Printable Form (fax or mail)
Details

$229.99
Single Registration
$199.99
2+ Group Rate: per person
*** All prices are shown in US Dollars ***
 
View brochure for CE details
Location

HOLIDAY INN TIMONIUM
9615 DEERECO ROAD
TIMONIUM, MD 21093
Phone:  410-560-1000
View Map

Alternate Locations

Student Discounts
If you are a student, please click here for registration information.

Group Discounts
If 5+ staff members from your facility are attending this event, please call (800) 844-8260 to learn more about our special rates.

Military Discount
If you are active or retired military personnel, please click here for registration information and select the Military tab.

In-House Options
If you would like this educational event brought to your facility, please click here for on-site training options.

Course Description:

Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.

This seminar will update and increase your knowledge of:
  • Neurobiological underpinnings of major DSM-5® diagnoses
  • Effects and side effects of drugs used to treat these diagnoses
  • Responsibilities of the non-prescribing therapist to clients taking psychiatric medication

Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this seminar is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders. You will leave this seminar with knowledge and confidence regarding effective and safe application of pharmacological drugs.

Objectives:

  1. Explain the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
  2. Define the role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
  3. Describe the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
  4. Compare the effects and side effects of various psychotropic medications, including antipsychotics, antidepressants, benzodiazepines and anticonvulsants.
  5. Discuss the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.
  6. Describe methods for prevention and early identification of prescription drug abuse among clients.
OUTLINE:

Psychopharmacological Foundations
Core Pharmacological Principles
  • Brain structures & circuits involved in:
    • Emotional regulation
    • Executive function & inhibitory control
    • Reward & pleasure
    • Learning & memory
  • Receptors and neurotransmitters important in the actions of psychopharmacological agents
    • Biogenic amines
    • Excitatory & inhibitory neurotransmitters
    • Endorphins & endocannabinoids
Your role in combined psychological & pharmacological treatments
  • Collaboration & communication with prescribing professionals
  • Managing the combined treatments
    • Referrals for medication
    • Client psycho-education
    • Monitoring drug effects & side effects
    • Promoting adherence to combined treatments
Drugs Used in the Treatment of DSM-5® Mental Disorders
  • Depressive Disorders
    • Neurobiology of depression
    • Drugs used to treat depressive disorders
      • Selective Serotonin Reuptake inhibitors (SSRIs)
        • Effects, side effects and cautions
        • Suicide risk & discontinuation syndrome
        • Serotonin syndrome
    • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
      • Effects, side effects, and cautions
    • Atypical antidepressant agents
      • Effects, side effects, and cautions
    • Tricyclic antidepressants (TCAs)
      • Effects, side effects, and cautions
      • Why were newer drugs needed?
    • MAO inhibitors
      • Effects, side effects, and cautions
    • Choosing an antidepressant
    • What if first-line antidepressants do not work?
      • Augmentation with antipsychotics
    • What about herbs like St. John’s Wort?
Schizophrenia Spectrum Disorders
  • Biological theories of schizophrenia
  • ”Typical” & “atypical” antipsychotic drugs
    • Effects, side effects & cautions – similarities & differences
  • Latest evidence-based comparisons
  • Drugs for treatment-resistant schizophrenia
  • Other uses of antipsychotic drugs
Bipolar Disorders
  • Biological theories for bipolar disorders
  • Drugs used to treat bipolar disorders
    • A prototype agent-lithium
      • Effects, side effects & cautions
    • Anticonvulsants
      • Effects, side effects & cautions
    • Antipsychotics – approved agents
    • Combination drug therapy
Anxiety, Obsessive-Compulsive & Sleep-Wake Disorders
  • The neurobiology of anxiety-related disorders
  • The structure of sleep
  • Drugs used in the treatment of anxiety & insomnia
    • Benzodiazepines & Benzodiazepine-like drugs
    • Misuse of these drugs in treatment
    • SSRI’s & other drugs used to treat anxiety
Attention-Deficit/Hyperactivity Disorder & Neurocognitive Disorders (Dementia)
  • ADHD
    • Psycho-stimulants
      • Effects, side effects & cautions
    • Alpha-Adrenergic Agonists
  • Major neurocognitive disorders
    • Drugs used in the treatment of cognitive impairment
    • Future treatments
Prescription Drug Abuse
  • Mental disorders & risk of comorbid prescription drug abuse
  • Classes of drugs that are frequently abused
    • Stimulants
    • Sedative-hypnotics
    • Opiates
  • Strategies for the prevention & early identification of prescription drug abuse
Limitations of the Research and Potential Risks
Target Audience

  • Counselors
  • Psychotherapists
  • Psychologists
  • Social Workers
  • Nurse Practitioners
  • Case Managers
  • Marriage & Family Therapists
  • Addiction Counselors
  • Nurses
  • Clinical Nurse Specialists
  • Pharmacists
  • School Psychologists
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Other Mental Health Professionals

ALAN S BLOOM, PH.D.

Alan S. Bloom, Ph.D., is professor of Pharmacology and Toxicology at the Medical College of Wisconsin where he teaches psychopharmacology to medical students and neuroscience graduate students. He earned a joint Ph.D. in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases.

Dr. Bloom has conducted extensive research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). He also directed research on the cognitive effects of chemotherapy drugs administered to women with breast cancer, commonly known as “chemo-brain”. His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA Center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin.

Dr. Bloom is a strong and experienced presenter providing lively, information-packed seminars. He encourages the active learning of participants through application of the material in case studies and problem-based learning. In 1997 he was elected to membership in the Medical College of Wisconsin Society of Teaching Scholars.



Speaker Disclosures:

Speaker Disclosures: Speaker Disclosure: Financial: Alan Bloom is a Professor of Pharmacology and Toxicology at the Medical College of Wisconsin. He receives a speaking honorarium from PESI, Inc.

Non-financial: Alan Bloom is the vice-chair for the State of Wisconsin Controlled Substances Board.
Credits listed below are for full attendance at the live event only. After attendance has been verified, pre-registered attendees will receive an email from PESI Customer Service with the subject line, “Evaluation and Certificate” within one week. This email will contain a link to complete the seminar evaluation and allow attendees to print, email or download a certificate of completion if in full attendance. For those in partial attendance (arrived late or left early), a letter of attendance is available through that link and an adjusted certificate of completion reflecting partial credit will be issued within 30 days (if your board allows). Please see “live seminar schedule” for full attendance start and end times. NOTE: Boards do not allow credit for breaks or lunch.

If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, or questions on home study credit availability, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

PESI, Inc. offers continuing education programs and products under the brand names PESI, PESI Healthcare, PESI Rehab and Psychotherapy Networker.




Addiction Counselors
This course has been approved by PESI, Inc., as a NAADAC Approved Education Provider, for 6.0 CE in the Counseling Services skill group. NAADAC Provider #77553. PESI, Inc. is responsible for all aspects of their programming. Full attendance is required; no partial credit will be awarded for partial attendance.


Counselors
This intermediate activity consists of 6.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

Maryland Counselors: This intermediate activity is approved for 6.25 clock hours of continuing education instruction. The Maryland Board of Professional Counselors recognizes courses and providers that are approved by the NAADAC. A certificate of attendance will be awarded at the end of the program to counselors who complete the program evaluation, to submit to their state board.


Marriage & Family Therapists
This activity consists of 380 minutes of continuing education instruction. Credit requirements and approvals vary per state board regulations. You should save this course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.


Nurses, Nurse Practitioners, and Clinical Nurse Specialists
American Nurses Credentialing Center Logo
PESI, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 6.3 contact hours. Partial contact hours will be awarded for partial attendance.


Pharmacology Nurse Practitioners
This program offers 380 instructional minutes of pharmacology content which is designed to qualify for 6.3 contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board.


Occupational Therapists & Occupational Therapy Assistants
AOTA Logo
PESI, Inc. is an AOTA Approved Provider of continuing education. Provider #: 3322. Full attendance at this course qualifies for 6.0 contact hours or .6 CEUs in the Category of Domain of OT and Occupational Therapy Process. Partial credit will be issued for partial attendance. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Course Level: Intermediate.


Pharmacists
ACPE Logo
PESI, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this Knowledge-based activity qualifies for 6.3 contact hours. ACPE Universal Program Number: 0289-0000-17-012-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. You are required to complete a program evaluation/post-test and bring your e-Profile ID to the seminar to receive CPE credit. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at www.nabp.net in order to obtain your NABP e-Profile ID.


Psychologists
This live activity consists of 6.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline and the certificate of completion you receive from this live activity. Contact us for more information on your state board or organization specific filing requirements. American Psychological Association credits are not available.

Psychologists/School Psychologists: PESI, Inc. is approved by the National Association of School Psychologists to offer professional development for school psychologists. PESI maintains responsibility for the program. Provider #1140. PESI is offering this activity for 6.25 hours of continuing education credit. Full attendance is required; no partial credits will be offered for partial attendance.


Social Workers
ASWB Logo
PESI, Inc., #1062, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PESI, Inc. maintains responsibility for this course. ACE provider approval period: January 27, 2017 - January 27, 2020. Social Workers completing this course receive 6.25 Clinical Practice continuing education credits. Course Level: Intermediate. Full attendance is required; no partial credits will be offered for partial attendance. A certificate of attendance will be awarded at the end of the program to social workers who complete the program evaluation.


Other Professions
This activity qualifies for 380 minutes of instructional content as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Credit Card Required for online registration | Contact us to redeem Gift Certificates